Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge

    Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge

    The world’s largest buyer of biopharmaceutical royalties has set up its first Asia-Pacific base in Hong Kong, joining a string of multinational corporations in the pharmaceutical sector establishing offices in the city as out-licensing deals by mainland Chinese biotechnology firms hit record highs. Royalty financing gives drug developers an alternative way to raise capital even…

    Read More
    Key Speakers at the China Development Forum

      Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration

      David Ricks, chief executive officer of Eli Lilly & Co., speaks during the China Development Forum in Beijing in March this year. Photographer: Qilai Shen/Bloomberg © 2026 Bloomberg Finance LP In the latest China pharmaceutical industry collaboration pact with a global drug leader, Abbisko said today it will work with U.S.-based Eli Lilly and Company…

      Read More